Ranbaxy
Sun-Ranbaxy merger: competition panel demands more details
28 Aug 2014
This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation
Ranbaxy faces fresh US penalty of Rs242 cr over Toansa-made API
22 Aug 2014
This is the second such penalty for the company, which paid $500 million to the US department of justice (DoJ) in May 201
EU lifts ban on Ranbaxy’s Toansa-made drugs
06 Jun 2014
European regulators on Thursday lifted the EU ban on drugs manufactured at Ranbaxy Laboratories' Toansa plant, saying they do not pose a risk to public health
AP High Court vacates stay on Ranbaxy-Sun Pharma merger
24 May 2014
The Andhra Pradesh High Court has vacated a stay on the proposed merger of Ranbaxy Laboratories with Sun Pharma over alleged insider trading in Ranbaxy shares ahead of the merger announcement
SC blasts manner of stalling Sun-Ranbaxy merger
21 May 2014
Sun Pharma denied the charge but said the share purchase by Silver Street, a limited-liability partnership firm owned by two subsidiaries of Sun Pharma, was being annulled
.webp)
